J.L. Pepin (Grenoble, France), R. Tamisier (Grenoble, France)
Surgery for obstructive sleep apnea: Sleep endoscopy determinants of outcome
I. Koutsourelakis, M. Ravesloot, E. Vagiakis, S. Zakynthinos, N. de Vries (Athens, Greece; Amsterdam, Netherlands)
|  |
BMI is not the driving factor in position dependent upper airway collapsibility in healthy subjects
C. Van Holsbeke, W. Vos, S. Vinchurkar, J. De Backer, O. Peters, N. Nadjmi, W. De Backer (Kontich, Edegem, Antwerpen, Belgium)
|  |
Clinical and polysomnographic determinants of snoring
I. Koutsourelakis, E. Vagiakis, E. Perraki, A. Minaritzoglou, S. Zakynthinos (Athens, Greece)
| |
Importance of Mallampati score as an independent predictor of obstructive sleep apnea
M.S. Kanwar, R.S. Jha (Delhi, Greater Kailash Part II, India)
| |
Validation of respiratory inductive plethysmography in people with obesity hypoventilation syndrome
C. Hollier, A. Harmer, L. Maxwell, C. Menadue, A. Piper, G. Willson (Sydney, Australia)
| |
Validation of raised serum bicarbonate for diagnosis of obesity hypoventilation syndrome
V. Macavei, K. Spurling, H. Makker (London, United Kingdom)
| |
Effects of supplemental O2 on PCO2 and ventilation in people with obesity hypoventilation syndrome
C. Hollier, A. Harmer, L. Maxwell, C. Menadue, G. Unger, G. Willson, A. Piper (Sydney, Australia)
| |
Multiscale entropy analysis of RR time series obtained from polysomnographic recordings in wide age spectrum group
J. Radlinski, Z. Baran, W. Tomalak (Rabka - Zdrój, Poland)
| |
Effect of nasal CPAP therapy on functional respiratory parameters and cardiopulmonary exercise test in obstructive sleep apnea syndrome
O. Oral Tapan, C. Sevinc, O. Itil, I. Oztura, M. Kayatekin, Y. Demiral (Karaman, Izmir, Turkey)
| |
End expiratory lung volume as a predictor of obstructive sleep apnea severity
J.A.J.M. Lebon, C.P.M. van der Grinten, G.J. de Vries (Sittard, Maastricht, Netherlands)
| |
Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome
S. Nural, E. Gunay, B. Halici, M. Unlu (Afyonkarahisar, Turkey)
| |
Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients
R. Plywaczewski, P. Bielen, L. Jonczak, M. Targowska, A. Czyzak-Gradkowska, D. Gorecka, P. Sliwinski (Warsaw, Poland)
| |
The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome
E. Elfimova, A. Litvin, K. Zykov (Moscow, Russian Federation)
| |
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients
R. Plywaczewski, L. Jonczak, P. Bielen, D. Gorecka, P. Sliwinski (Warsaw, Poland)
| |
Association between obstructive sleep apnea and elevated levels of B-type natriuretic peptide in a community based sample of women
M. Ljunggren, B. Lindahl, J. Theorell-Haglöw, E. Lindberg (Uppsala, Sweden)
| |
The relationship between uric acid levels and mean platelet volume and metabolic syndrome in males with with obstructive sleep apnoea syndrome
A. Akkaya, O. Öztürk, U.B. Khayri, M. Saygin, M. Has (Isparta, Turkey)
| |
Adaptive servo ventilation in the treatment of central sleep apnea related to ischemic stroke
A.K. Brill, R. Rösti, M. Gugger, S.R. Ott (Bern, Switzerland)
| |
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA)
A. Czyzak-Gradkowska, R. Plywaczewski, M. Targowska, L. Jonczak, P. Bielen, P. Sliwinski (Warsaw, Poland)
| |